Pediatric paraganglioma: An early manifestation of an adult disease secondary to germline mutations

Pediatric Blood and Cancer

Volumn 47, Issue 6, 2006, Pages 785-789

  Mora, Jaume ^a,c   Cascón, Alberto ^b   Robledo, Mercedes ^b   Catala, Albert ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c Hospital Sant Joan de Déu de Barcelona   (Spain)

Author keywords

Germline mutations; Hereditary cancer; Neurofibromatosis; Paraganglioma; Pheocromocytoma; SDH genes; VHL

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC SCREENING; GERM LINE; HUMAN; MALE; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION RATE; PARAGANGLIOMA; PRIORITY JOURNAL; SCHOOL CHILD; SCINTIGRAPHY; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; MUTATION; NEOPLASM RECURRENCE, LOCAL; PARAGANGLIOMA; PEDIGREE; POLYMERASE CHAIN REACTION; REOPERATION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33749178250     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20680     Document Type: Article

References (15)

1. Perel Y, Schlumberger M, Marguerite G, et al. Pheochromocytoma and paraganglioma in children: A report of 24 cases of the French Society of Pediatric Oncology. Pediatr Hematol Oncol 1997;14:413-422.
2. Caty MG, Coran AG, Geagen M, et al. Current diagnosis and treatment of pheochromocytoma in children. Experience with 22 consecutive tumors in 14 patients. Arch Surg 1990;125:978-981.
3. Neumann HP, Pawlu C, Peczkowska M, et al. European-American Paraganglioma Study Group. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943-951.
4. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma. Nat Genet 2000;26:268-270.
5. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2002;69:49-54.
6. Chandel NS, Schumacker PT. Cellular oxygen sensing by mitochondrias: Old question, new insight. J Appl Physiol 2000; 88:1880-1889.
7. Baysal BE, Ferrell RE, Willet-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene in hereditary paraganglioma. Science 2000;287:848-851.
8. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. Functional consequences of a SDHB gene mutation in an apparently sporadic Pheocromocytoma. J Clin Endocrinol Metab 2002;87:4771-4774.
9. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. The R22X mutation of the SDHD gene in the hereditary paraganglioma abolishes the enzimatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet 2001;69:1186-1197.
10. Neumann HP, Bausch B, McWhinney SR, et al. Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459-1466.
11. den Dunnen JT, Antonarakis E. Nomenclature for the description of human sequence variations. Hum Genet 2001;109:121-124.
12. Kaltsas G, Mukherjee JJ, Plowman PN, et al. The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumors. Clin Endocrinol 2001;55:575-587.
13. Pacak K, Linehan WM, Eisenhofer G, et al. Recent advances in genetics, diagnosis, localization and treatment of pheocromocytoma. Ann Inter Med 2001;134:315-329.
14. McDonnell CM, Benn DE, Marsh DJ, et al. K40E: A novel succinate dehydrogenase (SDH) B mutation causing familial phaeochomocytoma and paraganglioma. Clin Endoc 2004;61:510-514.
15. Vanharanta S, Buchta M, McWhinney SR, et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 2004;74:153-159.